United Therapeutics

YTD

ALL

Trade United Therapeutics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About UTHR

United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin.

CEO

Martine A. Rothblatt

CEOMartine A. Rothblatt

Employees

1,400

Employees1,400

Headquarters

Silver Spring, Maryland

HeadquartersSilver Spring, Maryland

Founded

1996

Founded1996

Employees

1,400

Employees1,400

UTHR Key Statistics

Market cap

23.98B

Market cap23.98B

Price-Earnings ratio

20.85

Price-Earnings ratio20.85

Dividend yield

—

Dividend yield—

Average volume

448.49K

Average volume448.49K

High today

—

High today—

Low today

—

Low today—

Open price

$569.18

Open price$569.18

Volume

0.00

Volume0.00

52 Week high

$609.35

52 Week high$609.35

52 Week low

$272.12

52 Week low$272.12

Stock Snapshot

United Therapeutics(UTHR) stock is priced at $564.94, giving the company a market capitalization of 23.98B. It carries a P/E multiple of 20.85.

On 2026-05-11, United Therapeutics(UTHR) stock opened at $569.18, reached a high of —, and a low of —.

The United Therapeutics(UTHR)'s current trading volume is 0, compared to an average daily volume of 448.49K.

In the last year, United Therapeutics(UTHR) shares hit a 52-week high of $609.35 and a 52-week low of $272.12.

UTHR News

TipRanks 4d

United Therapeutics reports Q1 EPS $5.82, consensus $6.86

Reports Q1 revenue $781.5M, consensus $797.38M. “In Q1, we extended our run of clinical success, with positive results from both our ADVANCE OUTCOMES and TETON-...

TipRanks 4d

United Therapeutics’ Earnings Call Signals Next Growth Phase

United Therapeutics Corp. ((UTHR)) has held its Q1 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock hedge fund-level da...

Investing.com 5d

United Therapeutics CEO Rothblatt sells $5.47m in stock - Investing.com

...

Analyst ratings

81%

of 16 ratings

Buy

81.3%

Hold

18.8%

Sell

More UTHR News

The Motley Fool 5d

UTHR Q1 2026 Earnings Transcript

Image source: The Motley Fool. Wednesday, May 6, 2026 at 9 a.m. ET CALL PARTICIPANTS Chairperson and Chief Executive Officer — Martine Rothblatt President and...

People also own

Based on the portfolios of people who own UTHR. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.